Edition:
United States

People: Seattle Genetics Inc (SGEN.OQ)

SGEN.OQ on NASDAQ Stock Exchange Global Select Market

63.78USD
2:15pm EDT
Change (% chg)

$0.56 (+0.89%)
Prev Close
$63.22
Open
$63.45
Day's High
$64.76
Day's Low
$63.36
Volume
57,107
Avg. Vol
443,125
52-wk High
$75.13
52-wk Low
$32.40

Simpson, Todd 

Mr. Todd E. Simpson serves as Chief Financial Officer of Seattle Genetics, Inc., since October 4, 2005. Previously, Mr. Simpson served from October 2001 to October 2005 as Vice President, Finance & Administration and Chief Financial Officer of Targeted Genetics Corporation, a biotechnology company. From January 1996 to October 2001, Mr. Simpson served as Vice President, Finance & Administration and CFO of Aastrom Biosciences, Inc., a biotechnology company. From August 1995 to December 1995, he served as Treasurer of Integra LifeSciences Corporation, a biotechnology company, which acquired Telios Pharmaceuticals, Inc., in August 1995. From 1992 until its acquisition by Integra, he served as Vice President of Finance and CFO of Telios and in various other finance-related positions. Mr. Simpson is a certified public accountant, and from 1983 to 1992 he practiced public accounting with the firm of Ernst & Young LLP. Mr. Simpson currently serves on the board of directors of Aquinox Pharmaceuticals, Inc., a publicly-traded pharmaceutical company, and on the executive committee of the board of directors of Life Sciences Washington. Mr. Simpson received a B.S. in Accounting and Computer Science from Oregon State University.

Basic Compensation

Total Annual Compensation, USD 727,282
Restricted Stock Awards, USD 665,550
Long-Term Incentive Plans, USD --
All Other, USD 678,979
Fiscal Year Total, USD 2,071,810

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 168,332 4,120,820.00
Name Fiscal Year Total

Clay Siegall

6,871,240

Todd Simpson

2,071,810

Eric Dobmeier

2,233,690

Jean Liu

1,881,380

Darren Cline

--

Jonathan Drachman

2,371,640
As Of  30 Dec 2015